van Pul, K. M., Notohardjo, J. C. L., Fransen, M. F., Koster, B. D., Stam, A. G. M., Chondronasiou, D., . . . de Gruijl, T. D. (2022). Local delivery of low-dose anti-CTLA-4 to the melanoma lymphatic basin leads to systemic Treg reduction and effector T cell activation. Science immunology, 7(73), eabn8097. https://doi.org/10.1126/sciimmunol.abn8097
Citace podle Chicago (17th ed.)van Pul, Kim M., et al. "Local Delivery of Low-dose Anti-CTLA-4 to the Melanoma Lymphatic Basin Leads to Systemic Treg Reduction and Effector T Cell Activation." Science Immunology 7, no. 73 (2022): eabn8097. https://doi.org/10.1126/sciimmunol.abn8097.
Citace podle MLA (9th ed.)van Pul, Kim M., et al. "Local Delivery of Low-dose Anti-CTLA-4 to the Melanoma Lymphatic Basin Leads to Systemic Treg Reduction and Effector T Cell Activation." Science Immunology, vol. 7, no. 73, 2022, p. eabn8097, https://doi.org/10.1126/sciimmunol.abn8097.